The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate if liraglutide
adjunct to insulin treatment changes the glucagon response during hypoglycaemia in subjects
with type 1 diabetes compared with conventional insulin treatment after 4 weeks' treatment
with liraglutide or placebo.
Subjects will initially be randomised to one of the three dose groups, and subsequently
randomly allocated to one of two treatment sequences (liraglutide/placebo or
placebo/liraglutide).